Mario Gonzalez Carbonell
Otolaryngology · Arecibo, PRNPI 1962938209
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (51.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Medtronic at 57.4% of the total. Reporting peaked in 2022 at $848 and has fallen 84.8% since, to $129 in 2025.
Across 15 payments — averaging $94.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$815
- Sanofi$169
- Novo Nordisk$147
- Takeda Pharmaceuticals U.S.A., Inc.$119
- Stryker$45
- AstraZeneca$34
- plus $91 from 3 others
What the payments were for
- Grants$73051%
- Food & beverage$65646%
- Education$342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $815 |
| Sanofi | 5 | $169 |
| Novo Nordisk | 1 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $119 |
| Stryker | 2 | $45 |
| AstraZeneca | 1 | $34 |
| Amgen | 1 | $34 |
| Innovation Technologies Inc | 1 | $33 |
| GSK | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NovoSeven RT$147
- CINRYZE$119
How this compares
$1,420 in reported general payments places this provider in the 80th percentile of 55 otolaryngology providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 31 | $117,244 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 430 | $31,965 |
| Fluticasone Propionate | 1,058 | $16,940 |
| Fluocinolone Acetonide Oil | 154 | $11,206 |
| Azelastine Hcl | 192 | $4,021 |
| Famotidine | 402 | $2,641 |
| Pantoprazole Sodium | 341 | $2,437 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 117 | $2,223 |
| Methylprednisolone | 147 | $1,330 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 18 | $1,189 |
| Ipratropium Bromide | 27 | $1,088 |
| Ofloxacin | 25 | $742 |
| Clotrimazole | 11 | $572 |
| Mupirocin | 53 | $390 |
| Levofloxacin | 35 | $283 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Arecibo
- Gabriel Rivera-RiveraArecibo$3K
- Mariano GonzalezArecibo$509
- Luis TarratsCayey$23K
- Juan Portela ArraizaManati$6K
- Jose BusquetsSan Juan$3K
- Mario Corona RuizPonce$3K
- Bianca Rullan OliverSan Juan$3K
- Miguel Garraton MartinSan Juan$2K
- Charles Juarbe SantosBayamon$2K
- Laureano Giraldez RodriguezGuaynabo$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.